Replies to post #340808 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

One R/S example you might find interesting and relevant is CYTR. Note CEO is considered seriously sketchy.

CYTR first proposed a R/S with no adjustment to shares outstanding. Shareholders rejected it. After some negotiation, a second R/S proposal with proportional shrinkage of SharesOut was approved.